Dihydroergotamine Mesylate and Pms-Sodium Polystyrene Sulfonate
Determining the interaction of Dihydroergotamine Mesylate and Pms-Sodium Polystyrene Sulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine Mesylate-Pneumococcal 13-valent conjugate vaccine
- Dihydroergotamine Mesylate-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Dihydroergotamine Mesylate-Pneumococcal Conjugate Vaccine (13-Valent)
- Dihydroergotamine Mesylate-Pneumococcal Conjugate Vaccine (7-Valent)
- Dihydroergotamine Mesylate-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Dihydroergotamine Mesylate-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pms-Sodium Polystyrene Sulfonate-Dihydroergotamine nasal
- Pms-Sodium Polystyrene Sulfonate-Dihydroergotamine Nasal Spray
- Pms-Sodium Polystyrene Sulfonate-Dilacor XR
- Pms-Sodium Polystyrene Sulfonate-Dilantin
- Pms-Sodium Polystyrene Sulfonate-Dilantin Infatabs
- Pms-Sodium Polystyrene Sulfonate-Dilantin injection